Dossier
resectable esophageal cancer
Coverage of resectable esophageal cancer in the Nexus archive.
- Evolution of Perioperative Immunotherapy in Resectable Esophageal Cancer
The article discusses the emergence and ongoing promise of immunotherapy for resectable esophageal cancer, a disease historically associated with poor prognosis. It highlights that immunotherapy has provided hope to patients and clinicians, with recent developments suggesting sustained or improved outcomes.